Canal Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Canal Capital Management's NVO Position: Q2 2026 in Review
Canal Capital Management reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $39.4K and leaving 6,524 shares worth $313K. The position accounts for 0.04% of the portfolio, ranked #184.
Canal Capital Management first reported a position in NVO in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.11M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Canal Capital Management held 6,524 shares of Novo Nordisk worth $313K as of Q2 2026.
- Canal Capital Management sold 918 Novo Nordisk shares in Q2 2026, an estimated $39.4K.
- Novo Nordisk made up 0.04% of Canal Capital Management's portfolio in Q2 2026, its #184 holding.
- Canal Capital Management first reported a position in Novo Nordisk in Q2 2020 and has held it in 25 quarters since.
- Canal Capital Management's Novo Nordisk position peaked at $1.11M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.